Advanced search    

Search: authors:"James E Galvin"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Reducing disability via a family centered intervention for acutely ill persons with Alzheimer’s disease and related dementias: protocol of a cluster-randomized controlled trial (Fam-FFC study)

Hospitalized older persons with Alzheimer’s disease and related dementias are at greater risk for functional decline and increased care dependency after discharge due to a combination of intrinsic factors, environmental, policy, and care practices that restrict physical and cognitive activity, lack of family involvement and limited staff knowledge of dementia care. We have...

Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings

National Institutes of Health (NIH) and the Michael J. Fox Foundation. James E Galvin has received grant support from NIH, Michael J Fox Foundation, Harry T. Mangurian Foundation, Lewy Body Dementia

Lewy body dementia: the impact on patients and caregivers

Lewy body dementia (LBD) is the second most common neurodegenerative dementia in older adults, yet there remains a delay in diagnosis that limits healthcare providers’ ability to maximize therapeutic outcomes and enhance patient and caregiver quality of life. The impact of LBD on patients includes limiting the potential exposure to medications that may cause adverse outcomes, and...

Responder analysis of a randomized comparison of the 13.3 mg/24 h and 9.5 mg/24 h rivastigmine patch

Grossberg 1 James E Galvin 7 Jeffrey L Cummings 5 6 Tillmann Krahnke 4 Christine Strohmaier 4 0 Alzheimer's Disease and Other Cognitive Disorders Unit, ICN, Hospital Clínic i Universitari, IDIBAPS